Market Dynamics: From Shortages to Price Pressures After prolonged supply constraints, the FDA officially declared US GLP-1 shortages resolved in April 2025, removing semaglutide and tirzepatide from its shortage list and ending enforcement discretion for compounded versions by May 2025
"Lip flip" patients are often categorized as having a "gummy-smile", whose upper lip may curl inward due to a thinning upper lip that disappears when smiling
You can get everything that you need for a successful routine, thanks to its convenient starter kits and vial formats
Commitment to Lifestyle Changes : Willingness to make sustainable changes to diet and exercise habits alongside medication treatment
Price cuts : Medicare will pay $245 per month, down from list prices of about $1,000 to $1,350
These manufacturing characteristics can limit the ability to quickly scale GLP-1 production capacity